News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
704,345 Results
Type
Article (42054)
Company Profile (473)
Press Release (661818)
Section
Business (208577)
Career Advice (2052)
Deals (35983)
Drug Delivery (97)
Drug Development (83396)
Employer Resources (170)
FDA (16349)
Job Trends (15068)
News (352463)
Policy (33041)
Tag
Academia (2626)
Alliances (50737)
Alzheimer's disease (1303)
Approvals (16287)
Artificial intelligence (155)
Bankruptcy (361)
Best Places to Work (11795)
Biotechnology (355)
Breast cancer (193)
Cancer (1405)
Cardiovascular disease (117)
Career advice (1711)
Cell therapy (301)
Clinical research (66481)
Collaboration (508)
Compensation (263)
COVID-19 (2609)
C-suite (114)
Data (1413)
Diabetes (176)
Diagnostics (6233)
Earnings (86130)
Employer resources (148)
Events (113542)
Executive appointments (402)
FDA (17032)
Funding (447)
Gene therapy (213)
GLP-1 (633)
Government (4431)
Healthcare (19059)
Infectious disease (2701)
Inflammatory bowel disease (118)
Interviews (319)
IPO (16622)
Job creations (3702)
Job search strategy (1460)
Layoffs (445)
Legal (7949)
Lung cancer (202)
Lymphoma (100)
Manufacturing (214)
Medical device (13366)
Medtech (13371)
Mergers & acquisitions (19512)
Metabolic disorders (478)
Neuroscience (1644)
NextGen Class of 2024 (6762)
Non-profit (4552)
Northern California (1716)
Obesity (273)
Opinion (204)
Patents (118)
People (57881)
Phase I (20862)
Phase II (29343)
Phase III (21696)
Pipeline (524)
Postmarket research (2602)
Preclinical (8941)
Radiopharmaceuticals (252)
Rare diseases (278)
Real estate (6004)
Regulatory (22133)
Research institute (2412)
Resumes & cover letters (355)
Southern California (1490)
Startups (3749)
United States (15605)
Vaccines (580)
Weight loss (198)
Date
Last 7 days (599)
Last 30 days (2395)
Last 365 days (36260)
2024 (36094)
2023 (41036)
2022 (52290)
2021 (56775)
2020 (54973)
2019 (47481)
2018 (35756)
2017 (33055)
2016 (32399)
2015 (38439)
2014 (32219)
2013 (27146)
2012 (29263)
2011 (29914)
2010 (28046)
Location
Africa (742)
Arizona (203)
Asia (38718)
Australia (6449)
California (3917)
Canada (1458)
China (310)
Colorado (175)
Connecticut (187)
Europe (84480)
Florida (537)
Georgia (135)
Illinois (398)
Indiana (227)
Maryland (642)
Massachusetts (3093)
Michigan (174)
Minnesota (296)
New Jersey (1124)
New York (1099)
North Carolina (802)
Northern California (1716)
Ohio (148)
Pennsylvania (934)
South America (1110)
Southern California (1490)
Texas (563)
Utah (110)
Washington State (413)
704,345 Results for "black diamond therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
November 4, 2024
·
1 min read
Genetown
Black Diamond Therapeutics to Participate in Jefferies 2024 Global Healthcare Conference
Black Diamond Therapeutics, Inc. announced that its Chief Executive Officer, Mark Velleca, M.D., Ph.D., will participate in a fireside chat at the Jefferies Global Healthcare Conference taking place June 4-6, 2024, in New York, NY.
May 29, 2024
·
1 min read
Business
Black Diamond Therapeutics Announces Changes to Board of Directors - April 11, 2024
Black Diamond Therapeutics, Inc. today announced that industry veterans Shannon Campbell and Prakash Raman, Ph.D., have been appointed to the Company’s Board of Directors.
April 11, 2024
·
5 min read
Genetown
Black Diamond Therapeutics to Participate in Upcoming April 2024 Investor Conferences
Black Diamond Therapeutics, Inc., a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer, announced its participation in upcoming investor conferences.
April 3, 2024
·
1 min read
Business
Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Black Diamond Therapeutics, Inc., a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer, reported financial results for the first quarter ended March 31, 2024, and provided a corporate update.
May 9, 2024
·
8 min read
Press Releases
Black Diamond Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
November 5, 2024
·
8 min read
Genetown
Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer, today announced forthcoming presentations during the 2024 ASCO Annual Meeting, taking place May 31 – June 4 in Chicago, IL.
April 24, 2024
·
3 min read
Genetown
Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Black Diamond Therapeutics, Inc. presented additional data from the Phase 1 dose escalation trial of BDTX-1535 in patients with recurrent glioblastoma, and initial data from a phase 0/1 “trigger” investigator-sponsored trial at the American Society of Clinical Oncology Annual Meeting.
June 1, 2024
·
7 min read
Business
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Black Diamond Therapeutics, Inc. today reported financial results for the fourth quarter and full year ended December 31, 2023, and provided a corporate update.
March 12, 2024
·
9 min read
Press Releases
Black Diamond Therapeutics Announces Restructuring Plan to Focus Resources on BDTX-1535 and Extend Cash Runway
October 7, 2024
·
5 min read
1 of 70,435
Next
